42 related articles for article (PubMed ID: 28810525)
21. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
[TBL] [Abstract][Full Text] [Related]
22. Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways.
Ding D; Wei S; Song Y; Li L; Du G; Zhan H; Cao Y
Cell Physiol Biochem; 2013; 32(6):1751-60. PubMed ID: 24356539
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Jiang G; Liu J; Ren B; Tang Y; Owusu L; Li M; Zhang J; Liu L; Li W
J Ethnopharmacol; 2016 Dec; 193():368-376. PubMed ID: 27566206
[TBL] [Abstract][Full Text] [Related]
24. Calcitriol inhibits migration and invasion of renal cell carcinoma cells by suppressing Smad2/3-, STAT3- and β-catenin-mediated epithelial-mesenchymal transition.
Xu S; Zhang ZH; Fu L; Song J; Xie DD; Yu DX; Xu DX; Sun GP
Cancer Sci; 2020 Jan; 111(1):59-71. PubMed ID: 31729097
[TBL] [Abstract][Full Text] [Related]
25. Osthole inhibits the tumorigenesis of hepatocellular carcinoma cells.
Lin ZK; Liu J; Jiang GQ; Tan G; Gong P; Luo HF; Li HM; Du J; Ning Z; Xin Y; Wang ZY
Oncol Rep; 2017 Mar; 37(3):1611-1618. PubMed ID: 28184928
[TBL] [Abstract][Full Text] [Related]
26. Osthole: A Multifunctional Natural Compound with Potential Anticancer, Antioxidant and Anti-inflammatory Activities.
Zafar S; Sarfraz I; Rasul A; Shah MA; Hussain G; Zahoor MK; Shafiq N; Riaz A; Selamoglu Z; Sarker SD
Mini Rev Med Chem; 2021; 21(18):2747-2763. PubMed ID: 32646359
[TBL] [Abstract][Full Text] [Related]
27. Use of coumarins as complementary medicine with an integrative approach against cervical cancer: background and mechanisms of action.
de la Cruz-Concepción B; Gutiérrez-Escobar A; Lorenzo-Moran HY; Navarro-Tito N; Martínez-Carrillo DN; Ortuño-Pineda C; Zacapala-Gómez AE; Torres-Rojas FI; Dircio-Maldonado R; Jiménez-Wences H; Sotelo Leyva C; Mendoza-Catalán MA
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7654-7667. PubMed ID: 34982427
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma.
Acharya N; Singh KP
WIREs Mech Dis; 2022 Nov; 14(6):e1575. PubMed ID: 35861307
[TBL] [Abstract][Full Text] [Related]
29. Osthole: An up-to-date review of its anticancer potential and mechanisms of action.
Yang S; Dai W; Wang J; Zhang X; Zheng Y; Bi S; Pang L; Ren T; Yang Y; Sun Y; Zheng Z; Wu S; Kong J
Front Pharmacol; 2022; 13():945627. PubMed ID: 36160431
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic Potential of Natural Products in the Treatment of Renal Cell Carcinoma: A Review.
Feng C; Lyu Y; Gong L; Wang J
Nutrients; 2022 May; 14(11):. PubMed ID: 35684073
[TBL] [Abstract][Full Text] [Related]
31. In vitro anticancer activities of osthole against renal cell carcinoma cells.
Liu L; Mao J; Wang Q; Zhang Z; Wu G; Tang Q; Zhao B; Li L; Li Q
Biomed Pharmacother; 2017 Oct; 94():1020-1027. PubMed ID: 28810525
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological features of osthole.
Jarząb A; Grabarska A; Skalicka-Woźniak K; Stepulak A
Postepy Hig Med Dosw (Online); 2017 May; 71(0):411-421. PubMed ID: 28513464
[TBL] [Abstract][Full Text] [Related]
33. Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms.
Ashrafizadeh M; Mohammadinejad R; Samarghandian S; Yaribeygi H; Johnston TP; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(8):918-931. PubMed ID: 32108003
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
